Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trialClinical Trial Published on 2022-03-012022-10-05 Journal: Vaccine [Category] SARS, 임상, [키워드] AEs baseline BNT162b2 BNT162b2 mRNA BNT162b2 vaccine Cancer clinical clinical trials COVID-19 COVID-19 pandemic COVID-19 vaccine death Efficacy Efficacy and safety excluded fatigue Follow-up follow-up time high risk Hospitalization immunosuppressive incidence rate individual Infection Injection-site pain malignancy Melanoma MOST neoplasm Neoplasms observer-blinded outcomes participant Participants Phase 3 Placebo placebo recipient placebo-controlled Prostate Pyrexia Randomized randomized clinical trial reactogenicity event receiving reported Safe Safety subgroup analysis therapy Trial unblinding Vaccine were excluded [DOI] 10.1016/j.vaccine.2021.12.046 PMC 바로가기 [Article Type] Clinical Trial
Impact of the COVID-19 lockdown in France on the diagnosis and staging of breast cancers in a tertiary cancer centre프랑스의 COVID-19 폐쇄가 3차 암 센터의 유방암 진단 및 병기 결정에 미치는 영향Article Published on 2022-03-012022-09-11 Journal: European Radiology [Category] SARS, 치료기술, [키워드] average Breast Breast cancer Cancer cancer centre cancers category clinical symptom Clinical symptoms COVID-19 database decrease demonstrated diagnosed Diagnosis distant metastasis evaluate Fisher Fisher's exact test Follow-up France Impact Invasion invasive ipsilateral lockdown Lymph node Mann-Whitney test neoplasm Neoplasm staging. Patient Prognosis proportions reduced searched staging symptomatic took place tumour Tumours [DOI] 10.1007/s00330-021-08264-3 PMC 바로가기 [Article Type] Article
Real-World Outcomes of Ruxolitinib Treatment for Polycythemia VeraArticle Published on 2022-02-252024-09-04 Journal: Clinical lymphoma, myeloma & leukemia [Category] 대상포진, [키워드] Myeloproliferative neoplasm phlebotomy response Splenomegaly [DOI] 10.1016/j.clml.2020.05.019 PMC 바로가기 [Article Type] Article
Mortality Among Adults With Cancer Undergoing Chemotherapy or Immunotherapy and Infected With COVID-19Research Published on 2022-02-212022-10-29 Journal: JAMA Network Open [Category] COVID-19, COVID19(2023년), MERS, SARS, [키워드] 95% CI active cancer age age and sex all-cause mortality Analysis anticancer association body mass index Cancer cancer treatment cancer type Care Chemotherapy Clinical diagnosis cohort study cohorts of patient Comorbidities Comorbidity conducted confounder country COVID-19 COVID-19 case COVID-19 diagnosis COVID-19 infection demographic characteristics evaluate Evidence exposure finding hematological hospital Hospitalization Immunotherapy Importance increase in increased mortality investigated IQR leukemia lower mortality lung cancer measure monitoring Mortality mortality rate neoplasm objective outcome participant Patient patients Patients with cancer plasmacytoma Point primary end point prospective cohort study receiving reduction in mortality Registered Relevance Result SACT setting Sex significantly smoking study period Subtypes syndrome the median Treatment with COVID-19 [DOI] 10.1001/jamanetworkopen.2022.0130 PMC 바로가기 [Article Type] Research
Neurological Prognostic Factors in Hospitalized Patients with COVID-19Article Published on 2022-01-302022-10-28 Journal: Brain Sciences [Category] COVID-19, [키워드] absence Admission clinical questionnaire cohort study Combination COVID-19 COVID-19 patient decreased mortality delirium Dizziness Factor fatigue headache Hospitalization in-hospital mortality increased the risk Infection interquartile range Male sex median age medical records neoplasm Neurological symptom Neurological symptoms NSS Older age Oxygen requirement Oxygen therapy Patient patients with COVID-19 patients with SARS-CoV-2 Poland predicted predictor Prognosis recruited risk SARS-COV-2 infection score Seizures stroke Symptom univariable analysis university with COVID-19 women [DOI] 10.3390/brainsci12020193 PMC 바로가기 [Article Type] Article
Variation in Cause-Specific Mortality Rates in Italy during the First Wave of the COVID-19 Pandemic: A Study Based on Nationwide DataArticle Published on 2022-01-122022-10-29 Journal: International Journal of Environmental Research an [Category] COVID-19, SARS, [키워드] age cause cause-specific mortality causes Causes of death cerebrovascular diseases chronic coronavirus disease country COVID-19 death diabete Diseases Epidemic explain females Gender hypertensive increase in Influenza Italy lombardy male Mortality mortality rate National neoplasm pandemic Pneumonia Rate reduced respiratory diseases Sex Transport Variation Wave [DOI] 10.3390/ijerph19020805 PMC 바로가기 [Article Type] Article
Incidence of myeloid neoplasms in Spain (2002–2013): a population-based study of the Spanish network of cancer registriesArticle Published on 2022-01-102022-10-04 Journal: Scientific Reports [Category] 바이오마커, [키워드] calculated Cancer Comprehensive Epidemiology estimate expected hematological cancer highlight incidence incidence rate leukemia Lineage MDs Myelodysplastic syndrome Myeloproliferative disease myeloproliferative neoplasm neoplasm NOS public health authorities robust Spain Spanish subtype the WHO These data Variability [DOI] 10.1038/s41598-021-03734-6 PMC 바로가기 [Article Type] Article
Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United StatesResearch Published on 2022-01-042022-10-29 Journal: JAMA Network Open [Category] COVID-19, [키워드] 30-Day mortality 30-day mortality rate 95% CI adjusted adjusted odds ratio Admission age all-cause mortality assessment association Attention black Cancer Cancer center Care Characteristics cohort study collected Community continuum COVID-19 COVID-19 diagnosis COVID-19 pandemic death Diagnosis division divisions exposure female finding help heterogeneity higher risk Hispanic Importance IMPROVE individuals intensive care invasive laboratory-confirmed SARS-CoV-2 infection less measure mechanical ventilation median mixed-effects model mortality rate neoplasm no significant difference objective oncology outcome outcomes participant Patient patient population Patients with cancer Point Primary outcome quantified ranged Regional Relevance reported resource Result retrospective cohort study risk factor Secondary outcomes setting severe complication significant difference significantly South spatiotemporal statistically significant difference the United State The United States Treatment Variation vulnerable patients West [DOI] 10.1001/jamanetworkopen.2021.42046 PMC 바로가기 [Article Type] Research
Differences in the Impact of COVID-19 on Pathology Laboratories and Cancer Diagnosis in GironaObservational Study Published on 2021-12-162022-10-04 Journal: International Journal of Environmental Research an [Category] SARS, 임상, [키워드] Cancer cancer diagnosis Care Central nervous system Colon consequence COVID-19 COVID-19 pandemic Date decrease determine diagnose Diagnosis difference displaying effort evaluate Follow-up hospital Impact kidney Laboratory malignancy Melanoma morphology neoplasm Neoplasms observational study pandemic Pathologies pathology Probability rectum reduced reduction in resource Sample Spain statistically significant urinary system [DOI] 10.3390/ijerph182413269 PMC 바로가기 [Article Type] Observational Study
Changes in breast cancer screening rates among 32 community health centers during the COVID-19 pandemicArticle Published on 2021-12-012023-06-19 Journal: Cancer [Category] MERS, [키워드] access Breast cancer screening Community health centers Coronavirus disease 2019 (COVID-19) Disparities neoplasm [DOI] 10.1002/cncr.33859 PMC 바로가기